P. Mehta, V. Thummar, and H. Bhavsar, “Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India”, Int J Res Med Sci, vol. 14, no. 4, pp. 1584–1588, Mar. 2026.